Melanoma/Skin Cancer News

As they work to anticipate and meet the needs of their loved ones, caregivers of individuals with cancer often struggle with their own complex emotional, physical and social concerns.

Obesity appeared associated with improved immunotherapy outcomes among patients with certain cancer types, according to a cohort study published in JAMA Network Open.

CHICAGO – Healio gathered the best, brightest and boldest group of oncologists during the ASCO Annual Meeting in Chicago to celebrate our inaugural Healio Disruptive Innovators.

CLEVELAND — Cutaneous T-cell lymphomas can often have different manifestations in the skin, according to Kevin D. Cooper, MD, chair of dermatology at Case Western Reserve University School of Medicine.

CHICAGO —Adding relatlimab to nivolumab improved PFS, OS and objective response rates across key subgroups of patients with previously untreated metastatic or unresectable melanoma, according to a study presented at ASCO Annual Meeting.

U.S. veterans were diagnosed with melanoma at later stages compared with those individuals included in the Surveillance, Epidemiology and End Results program, though both populations exhibited recent improvement, according to a study.

In its 2022 Cancer Disparities Progress Report, American Association for Cancer Research discussed advances made in closing substantial gaps in care while underscoring the need for further progress.

CHICAGO — Adjuvant pembrolizumab significantly improved distant metastasis-free survival among patients with resected stage IIB or IIC melanoma, according to results of the phase 3 KEYNOTE-716 presented at ASCO Annual Meeting.

CHICAGO — Patients and prescribers should be more aware of the potential for major adverse cardiac events after immune checkpoint inhibitor-based therapy, according to retrospective study results presented at ASCO Annual Meeting.

Women demonstrated a 34% increased risk for severe adverse events from any cancer treatment compared with men, according to a study published in Journal of Clinical Oncology.